Skip to content

    Dabur India

    DABUR
    Fast Moving Consumer Goods·7 May 2026
    Management Summary

    Dabur India reported a strong Q4 FY26 with consolidated revenue up 7.3% and domestic FMCG growing 9.5% driven by 6% volume growth. HPC and Health Care segments showed robust performance, with significant market share gains in key categories. However, geopolitical issues in the Middle East led to muted international growth and rising input costs, prompting price increases. Management expects sequential recovery and continued double-digit growth in key segments.

    Highlights

    5
    • Consolidated revenue grew by 7.3% year-on-year, with domestic FMCG business growing at 9.5% backed by 6% volume growth.

    • HPC portfolio recorded strong momentum, growing 17% during the quarter, with Hair Oil up 28% and Shampoo up 20%.

    • Home Care portfolio delivered robust 24% growth, driven by Odonil (20%), Odomos (48%), and Sanifresh (over 20%).

    • Health care categories like Hajmola (12.7%), Isabgol (over 50%), Honey (over 20%), and Honitus (over 36%) showed strong growth.

    • Operating profit grew by 8.2% and reported PAT grew by 15%.

    Concerns

    4
    • Geopolitical headwinds in the Middle East are impacting input costs and supply chain across businesses.

    • Inflation has picked up to around 10% across many portfolios, necessitating 4% price increases.

    • Glucose portfolio was impacted by unseasonal rains in March, and the overall health care business saw a mid-single digit decline due to this.

    • International business reported a muted growth of 2.5% in INR terms, impacted by the war in West Asia, supply chain disruptions, and demand due to expats leaving.

    Key financials

    Single quarter

    05 metrics
    1. 01Consolidated Revenue Growth7.3%+7.3%YoY
    2. 02Domestic FMCG Growth9.5%+9.5%YoY
    3. 03Domestic FMCG Volume Growth6%+6%YoY
    4. 04Operating Profit Growth8.2%+8.2%YoY
    5. 05PAT Growth15%+15%YoY

    Segment breakdown

    HPC Portfolio (India)
    17% Growth
    Hair Oil Portfolio
    28% Growth
    Shampoo Portfolio
    20% Growth
    Home Care Portfolio
    24% Growth
    Odonil Growth
    20% Growth
    Odomos Growth
    48% Growth
    Sanifresh Growth
    20% Growth
    Skin Care Portfolio
    10% Growth
    Toothpaste Portfolio
    7.2% Growth
    Digestive Portfolio
    15% Growth
    Hajmola Franchise Growth
    12.7% Growth
    Isabgol Growth
    50% Growth
    Honey Portfolio Growth
    20% Growth
    Honitus Growth
    36% Growth
    Ayurvedic Health Juices Growth
    30% Growth
    Lal Tail Growth
    10% Growth
    Premium Beverage Portfolio Growth
    26% Growth
    Coconut Water Growth
    100% Growth
    Culinary Business Growth
    30% Growth
    International Business Growth (INR terms)
    2.5% Growth
    Sub-Saharan Africa Growth
    20% Growth
    U.K. and EU Growth
    10% Growth
    Hobi Growth
    16.5% Growth
    Bangladesh Business Growth
    22% Growth
    Namaste U.S. Growth
    6.2% Growth
    List

    Guidance & targets

    10
    CategoryTargetPriority
    Overall Growth
    Revenue Growth
    high single to a low double-digit growth
    Medium
    HPC
    HPC Growth
    double digit, if not high teens. At least a double digit
    High
    Oral Care
    Oral Care Growth
    double digits
    High
    Home Care
    Home Care Growth
    sustain that growth [24%]
    Medium
    Food & Beverages
    F&B Growth
    double-digit growth
    Medium
    Badshah Business
    Badshah Business Growth
    continue that trajectory [12%]
    Medium
    International Business
    International Business Growth
    double digits
    Medium
    Margins
    Operating Margins
    sequentially improve
    High
    Margins
    Operating Margins
    improve year-on-year
    High
    Pricing
    Price Increases
    4%
    High

    Sequential recovery in India business

    next quarter
    CurrentExpected to continue
    TargetSustained growth driven by volume and price

    Why it matters

    Indicates the health and momentum of the core domestic market amidst inflation.

    I think the growth trajectory should continue and sequential recovery should continue that will be driven partly by volume and partly by price.

    How to verify

    key_financials.metrics[label='Domestic FMCG Growth']

    Risks & concerns

    5
    RiskSeverity

    Geopolitical headwinds in the Middle East

    Impacting input costs and supply chain across businesses, including India, and causing muted international business growth.Management acknowledged

    high

    Input cost inflation

    Inflation of around 10% is hitting many portfolios, necessitating price increases to mitigate impact.Management acknowledged

    high

    El Nino impact / unseasonal rains

    Unseasonal rains in March impacted the glucose portfolio and could affect summer-centric products like beverages if severe summer conditions do not materialize.Management acknowledged

    medium

    Volume suppression due to price hikes

    Inflation leading to price hikes could suppress volumes, though management aims for a balance of volume and price-led growth.Management acknowledged

    medium

    International business challenges (MENA region)

    War in West Asia causing supply chain disruptions, inflation, and demand reduction due to expats leaving, leading to muted growth.Management acknowledged

    high

    Q&A highlights

    8

    “Yes. So, we think that in quarter 1, the growth will sustain. In HPC at least, we are seeing good traction in the month of April also. In health care portfolio, barring glucose, which is impacted by unseasonal rains here, we see rest parts of the portfolio doing well for us.”

    Analyst sought clarity on the sustainability of strong growth numbers and potential one-offs, which management addressed by confirming sustained growth expectations for Q1.

    asked by Abneesh Roy

    2 min read6 chapters

    Detailed Narrative

    01

    Strong Domestic FMCG Performance Driven by Volume Growth

    Dabur India delivered a robust Q4 FY26 with consolidated revenue growing 7.3% year-on-year. The domestic FMCG business was a key driver, expanding by 9.5%, significantly supported by a 6% volume growth. This performance reflects strong consumption resilience in India, backed by fiscal measures and a narrowing gap between urban and rural demand.

    02

    HPC Portfolio Leads Growth Across Categories

    The HPC portfolio maintained strong momentum, recording a double-digit growth of 17% during the quarter. This was fueled by exceptional performance in Hair Care, with Hair Oil growing 28% and Shampoo 20%. The Home Care segment also saw robust growth of 24%, with Odonil up 20%, Odomos up 48%, and Sanifresh over 20%. Skin Care also registered double-digit growth.

    03

    Health Care and F&B Show Mixed Results

    Within the Health Care category, the digestive portfolio grew in mid-teens, with Hajmola up 12.7% and Isabgol over 50%. Health supplements like Honey grew over 20%, and Honitus saw over 36% growth. However, the Glucose portfolio was impacted by unseasonal rains in March. The Beverages portfolio saw a sequential recovery, with premium beverages growing 26% and Coconut Water up 100%, while the Culinary business grew 30%.

    04

    International Business Muted by Geopolitical Headwinds

    The international business reported a muted growth of 2.5% in INR terms. This was primarily due to the war in West Asia, which impacted the MENA region through supply chain disruptions, inflation, and reduced demand as expats left. Despite this, some regions like Sub-Saharan Africa (20%), U.K. and EU (10%), and Bangladesh (22%) showed strong growth.

    05

    Inflationary Pressures and Pricing Strategy

    The company is facing significant inflationary pressures, with inflation picking up to around 10% across many portfolios. To mitigate this, Dabur has already announced a 4% price increase across different parts of the business. Management indicated a strategy of price increases on larger packs and 'shrinkflation' on smaller, low-unit-price packs to protect margins and balance volume growth.

    06

    Focus on Margin Improvement and Premiumization

    Dabur is committed to improving margins sequentially and year-on-year. This will be achieved through a combination of price increases, product mix improvements, cost-saving initiatives, and a continued focus on premiumization. The company aims to prioritize margin protection, especially in a high-inflation environment, while also investing in brand building and GTM transformation.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.